Abstract Book
|
Symposium Audio Presentations
Instructions for audio web-casting
|
Opening of Symposium
W J Remme (Utrecht, Netherlands)
|
Part I
Adrenergic blockade – Critical success factors for stopping disease
progression within the cardiovascular continuum
|
Chairperson's Introduction
L Rydén (Stockholm, Sweden)
|
The cardiovascular disease continuum –
The role of the adrenergic system and its blockade
M Böhm (Cologne, Germany)
|
The role of peripheral resistance
T Lüscher (Zurich, Switzerland)
|
The role of left ventricular dysfunction post myocardial infarction
H Dargie (Glasgow, United Kingdom)
|
Opening of Symposium Part II
L Rydén (Stockholm, Sweden)
|
Part II
Adrenergic blockade – clinical update on treatment of heart failure
patients
|
Chairperson's Introduction
W J Remme (Utrecht, Netherlands)
|
Antiadrenergic therapy in mild to moderate chronic heart failure
Are there differences between beta-blocking agents
M Fowler (Stanford, CA, USA)
|
Antiadrenergic therapy in severe chronic heart failure
Previous clinical trial evidence
H Krum (Melbourne, Australia)
|
Antiadrenergic therapy in severe chronic heart failure
The COPERNICUS trial
M Packer (New York, NY, USA)
|
Satellite Symposium -
